Arsenic Trioxide Inhibits Cholangiocarcinoma Cell Growth and induces Apoptosis
Arsenic Trioxide Inhibits Cholangiocarcinoma Cell Growth and induces Apoptosis
复制标题
DOI:
10.1007/s12253-009-9234-1
复制
发表时间:
2010-09-01
影响因子:
2.8
通讯作者:
Wu, Xiangyuan
中科院分区:
文献类型:
--
作者:
Zhong, Fei;Zhang, Shineng;Wu, Xiangyuan
Arsenic trioxide (As2O3), an ingredient in many traditional Chinese medicines, has drawn broad attention due to its therapeutic effects on a variety of cancers, including some solid tumors. However, the effects of As2O3 on cholangiocarcinoma have not been reported. In the present study, we demonstrate for the first time that clinically obtainable concentrations of As2O3 inhibit cell growth and induce apoptosis in human cholangiocarcinoma SK-ChA-1 cells. As2O3-induced apoptosis was partially inhibited by caspase inhibitor and accompanied by changes in the expression of Bcl-2 family proteins, decrease of mitochondrial membrane potential (MMP), release of cytochrome C from mitochondria, activation of caspase-3, caspase-9, and cleavage of poly (ADP-ribose) polymerase (PARP). Thus As2O3 induces apoptosis in SK-ChA-1 cells via mitochondria-mediated, caspases-dependent pathways. As2O3 inhibition of Akt phosphorylation may contribute to As2O3-mediated cholangiocarcinoma cell growth inhibition and apoptosis induction.